CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
COSCIENS Biopharma Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 20-F on Mar 25, 2026
$6.49+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $24.10M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns COSCIENS Biopharma's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Goodwood Fund | 257,257 | 8.20% | 13D (active) amendment | Dec 19, 2024 |
| Peter Puccetti | 257,257 | 8.20% | 13D (active) amendment | May 30, 2025 |